Evidence map›Paper›PMID 32180727›Full record

ArticleFrontiers in pharmacology2020

Amentoflavone Attenuates

Shui Liu, Xiaofeng Yang, Hong Zhang, Jian Zhang, Yonglin Zhou, Tingting Wang, Naiyu Hu, Xuming Deng, Xiaoxue Bai, Jianfeng Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Novel Insights into the Therapeutic Effect of Amentoflavone AgainstInternational journal of molecular sciences · 2025
    Article
  3. Microorganisms · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Piceatannol AlleviatesMolecules (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Review
  10. Pathogenic Characterization ofFrontiers in microbiology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shui LiuCadre's Ward, The First Hospital of Jilin University, Jilin University, Changchun, China.
Xiaofeng YangCadre's Ward, The First Hospital of Jilin University, Jilin University, Changchun, China.
Hong ZhangCadre's Ward, The First Hospital of Jilin University, Jilin University, Changchun, China.
Jian ZhangKey Laboratory of Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Institute of Zoonosis, Jilin University, Changchun, China.
Yonglin ZhouKey Laboratory of Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Institute of Zoonosis, Jilin University, Changchun, China.
Tingting WangKey Laboratory of Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Institute of Zoonosis, Jilin University, Changchun, China.
Naiyu HuCollege of Animal Sciences, Jilin University, Changchun, China.
Xuming DengCadre's Ward, The First Hospital of Jilin University, Jilin University, Changchun, China.
Xiaoxue BaiCadre's Ward, The First Hospital of Jilin University, Jilin University, Changchun, China.
Jianfeng WangCadre's Ward, The First Hospital of Jilin University, Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-toxinamentoflavoneClostridium perfringensgas gangreneperfringolysin O

Identifiers

PMID32180727
PMCPMC7059699
OpenAlexW3007775021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.